Literature DB >> 12897733

Asthma morbidity during pregnancy can be predicted by severity classification.

Michael Schatz1, Mitchell P Dombrowski, Robert Wise, Elizabeth A Thom, Mark Landon, William Mabie, Roger B Newman, John C Hauth, Marshall Lindheimer, Steven N Caritis, Kenneth J Leveno, Paul Meis, Menachem Miodovnik, Ronald J Wapner, Richard H Paul, Michael W Varner, Mary Jo O'sullivan, Gary R Thurnau, Deborah Conway, Donald McNellis.   

Abstract

BACKGROUND: The 1993 National Asthma Education Program Working Group on Asthma and Pregnancy defined asthma severity as mild, moderate, or severe on the basis of symptoms and spirometry, but no studies have evaluated the relationship between this classification system and subsequent asthma morbidity during pregnancy.
OBJECTIVE: The objective of this study was to evaluate the relationship between asthma severity classification during pregnancy and gestational asthma exacerbations.
METHODS: Asthma severity was defined according to the 1993 classification, adjusted to include medication requirements, in a volunteer sample of 1739 pregnant asthmatic patients who were less than 26 weeks' gestation.
RESULTS: Initial asthma classification (mild, moderate, or severe) was significantly related to subsequent asthma morbidity during pregnancy (hospitalizations, unscheduled visits, corticosteroid requirements, and asthma symptoms during labor and delivery). Exacerbations during pregnancy occurred in 12.6% of patients initially classified as mild, 25.7% of patients classified as moderate, and 51.9% of patients classified as severe (P <.001). Asthma morbidity was similar, whether patients were classified as moderate or severe by symptoms and spirometry or by medication requirement. Thirty percent of initially mild patients were reclassified as moderate-severe during pregnancy, and 23% of the initially moderate-severe patients were reclassified as mild later in pregnancy; asthma morbidity in these patients changed accordingly.
CONCLUSION: The National Asthma Education Program Working Group on Asthma and Pregnancy classification of asthma severity, adapted to include medication use, predicts subsequent asthma morbidity during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897733     DOI: 10.1067/mai.2003.1516

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  54 in total

1.  Effect of pregnancy on maternal asthma symptoms and medication use.

Authors:  Kathleen Belanger; Melissa E Hellenbrand; Theodore R Holford; Michael Bracken
Journal:  Obstet Gynecol       Date:  2010-03       Impact factor: 7.661

Review 2.  Asthma in pregnancy.

Authors:  Evelyne Rey; Louis-Philippe Boulet
Journal:  BMJ       Date:  2007-03-17

Review 3.  Asthma in pregnancy: a review.

Authors:  Warwick Giles; Vanessa Murphy
Journal:  Obstet Med       Date:  2013-05-03

4.  Asthma in pregnancy and its pharmacologic treatment.

Authors:  Carol Louik; Michael Schatz; Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Ann Allergy Asthma Immunol       Date:  2010-08       Impact factor: 6.347

5.  Racial and ethnic disparities in severe maternal morbidity prevalence and trends.

Authors:  Stephanie A Leonard; Elliott K Main; Karen A Scott; Jochen Profit; Suzan L Carmichael
Journal:  Ann Epidemiol       Date:  2019-02-28       Impact factor: 3.797

Review 6.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

7.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Asthma Outcomes and Management During Pregnancy.

Authors:  Catherine A Bonham; Karen C Patterson; Mary E Strek
Journal:  Chest       Date:  2017-09-01       Impact factor: 9.410

9.  Perinatal complications associated with maternal asthma during pregnancy.

Authors:  Stephanie Johnston; Joanne Said
Journal:  Obstet Med       Date:  2012-02-09

10.  Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.

Authors:  Moumita Sarkar; Gideon Koren; Sanjog Kalra; Angela Ying; Carlo Smorlesi; Marco De Santis; Orna Diav-Citrin; Meytal Avgil; Sharon Voyer Lavigne; Matti Berkovich; Adrienne Einarson
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.